Roles of the m6A Modification of RNA in the Glioblastoma Microenvironment as Revealed by Single-Cell AnalysesFeng Yuan, Chiyuan Ma, Aifeng Zhang et al.|Frontiers in Immunology|2022Cited by 33
BACH1 as a potential target for immunotherapy in glioblastomasFeng Yuan, Chiyuan Ma, Zixiang Cong et al.|International Immunopharmacology|2021Cited by 21
A Novel Immune Classification for Predicting Immunotherapy Responsiveness in Patients With Adamantinomatous CraniopharyngiomaFeng Yuan, Chiyuan Ma, Xiangming Cai et al.|Frontiers in Neurology|2021Cited by 17
N6-methyladenosine-related microRNAs risk model trumps the isocitrate dehydrogenase mutation status as a predictive biomarker for the prognosis and immunotherapy in lower grade gliomasFeng Yuan, Chiyuan Ma, Yingshuai Wang et al.|Exploration of Targeted Anti-tumor Therapy|2022Cited by 2
Comprehensive analysis of m6A subtype classification for immune microenvironment of pituitary adenomasFeng Yuan, Chiyuan Ma, Xiangming Cai et al.|International Immunopharmacology|2023Cited by 2